PCSK9 and atherosclerosis: Unlike aging of Ldlr−/− and ApoE−/− mice, in which atherosclerosis and aging progress in parallel, the AAV-PCSK9 model allows us to induce atherosclerosis in young versus aged C57Bl/6 mice upon an acute elevation of plasma lipids and to investigate the impact of immunosenescence on atherosclerosis development.